Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Ischemic Heart Disease

Free Subscription Articles published in JAMA Retrieve available abstracts of 119 articles: HTML format

Single Articles

September 2022
1. HUDSON JA, Majonga ED, Ferrand RA, Perel P, et al
   Association of HIV Infection With Cardiovascular Pathology Based on Advanced Cardiovascular Imaging: A Systematic Review.
   JAMA. 2022;328:951-962.
   PubMed     Abstract available
   
   
   
2. FEINSTEIN MJ
   HIV, Subclinical Cardiovascular Disease, and Clinical Progression: Insights From Immunologic Heterogeneity.
   JAMA. 2022;328:931-932.
   PubMed    
   
   
   
3. CALDERON AT, Sanz-Sanchez J, Garcia-Garcia HM
   Alirocumab Added to High-Intensity Statin Therapy and Coronary Atherosclerosis in Patients With Acute Myocardial Infarction.
   JAMA. 2022;328:891.
   PubMed    
   
   
   
4. BENSON VM
   Alirocumab Added to High-Intensity Statin Therapy and Coronary Atherosclerosis in Patients With Acute Myocardial Infarction.
   JAMA. 2022;328:890-891.
   PubMed    
   
   
   
5. RABER L, Koskinas KC
   Alirocumab Added to High-Intensity Statin Therapy and Coronary Atherosclerosis in Patients With Acute Myocardial Infarction-Reply.
   JAMA. 2022;328:891-892.
   PubMed    
   
   
   
6. SLOMSKI A
   Benefit of Dapagliflozin When Used With Cardiovascular Medications in Patients With Type 2 Diabetes.
   JAMA. 2022;328:817.
   PubMed    
   
   
   
7. JAMES MT, Har BJ, Tyrrell BD, Faris PD, et al
   Effect of Clinical Decision Support With Audit and Feedback on Prevention of Acute Kidney Injury in Patients Undergoing Coronary Angiography: A Randomized Clinical Trial.
   JAMA. 2022;328:839-849.
   PubMed     Abstract available
   
   
   August 2022
8. CHOU R, Cantor A, Dana T, Wagner J, et al
   Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
   JAMA. 2022;328:754-771.
   PubMed     Abstract available
   
   
   
9. JIN J
   Statins for the Prevention of Cardiovascular Disease.
   JAMA. 2022;328:786.
   PubMed    
   
   
   
10. MANGIONE CM, Barry MJ, Nicholson WK, Cabana M, et al
    Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2022;328:746-753.
    PubMed     Abstract available
    
    
    
11. LO RE V 3RD, Dutcher SK, Connolly JG, Perez-Vilar S, et al
    Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients.
    JAMA. 2022;328:637-651.
    PubMed     Abstract available
    
    
    
12. SARKAR U, Bibbins-Domingo K
    Achieving Diagnostic Equity in Cardiovascular Disease.
    JAMA. 2022 Aug 15. pii: 2795499. doi: 10.1001/jama.2022.14424.
    PubMed    
    
    
    
13. LI L, Scott CA, Rothwell PM
    Association of Younger vs Older Ages With Changes in Incidence of Stroke and Other Vascular Events, 2002-2018.
    JAMA. 2022;328:563-574.
    PubMed     Abstract available
    
    
    
14. RAO SV, Ohman EM
    Balancing the Risks and Benefits of Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery.
    JAMA. 2022;328:532-533.
    PubMed    
    
    
    
15. WUNNAVA S, Miller TA, Narang C, Nathan M, et al
    US Food and Drug Administration Approval of High-risk Cardiovascular Devices for Use in Children and Adolescents, 1977-2021.
    JAMA. 2022;328:580-582.
    PubMed    
    
    
    
16. SANDNER S, Redfors B, Angiolillo DJ, Audisio K, et al
    Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis.
    JAMA. 2022;328:554-562.
    PubMed     Abstract available
    
    
    
17. ANDERSON JL, Knowlton KU
    Cardiovascular Events and Gout Flares.
    JAMA. 2022;328:425-426.
    PubMed    
    
    
    
18. CIPOLLETTA E, Tata LJ, Nakafero G, Avery AJ, et al
    Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With Gout.
    JAMA. 2022;328:440-450.
    PubMed     Abstract available
    
    
    July 2022
19. PATNODE CD, Redmond N, Iacocca MO, Henninger M, et al
    Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors: Updated Evidence Report and Systematic Review for the US Preventive
    JAMA. 2022;328:375-388.
    PubMed     Abstract available
    
    
    
20. MANGIONE CM, Barry MJ, Nicholson WK, Cabana M, et al
    Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2022;328:367-374.
    PubMed     Abstract available
    
    
    
21. SHUFELT CL, Mora S, Manson JE
    Aspirin for the Primary Prevention of Atherosclerotic Cardiovascular Disease in Women.
    JAMA. 2022 Jul 25. pii: 2794800. doi: 10.1001/jama.2022.11951.
    PubMed    
    
    
    
22. KIM YE, Huh K, Park YJ, Peck KR, et al
    Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection.
    JAMA. 2022 Jul 22. pii: 2794753. doi: 10.1001/jama.2022.12992.
    PubMed    
    
    
    
23. LINDLEY KJ, Teal SB
    Contraception in Women With Cardiovascular Disease.
    JAMA. 2022 Jul 22. pii: 2794754. doi: 10.1001/jama.2022.11541.
    PubMed    
    
    
    
24. ABBASI J
    MASALA Study Probes Why People With South Asian Ancestry Have Increased Cardiovascular Disease Risks.
    JAMA. 2022 Jul 13. pii: 2794433. doi: 10.1001/jama.2022.11417.
    PubMed    
    
    
    
25. ELDRIDGE N, Wang Y, Metersky M, Eckenrode S, et al
    Trends in Adverse Event Rates in Hospitalized Patients, 2010-2019.
    JAMA. 2022;328:173-183.
    PubMed     Abstract available
    
    
    
26. SLOMSKI A
    High HDL Cholesterol Linked With Death in Coronary Artery Disease.
    JAMA. 2022;328:10.
    PubMed    
    
    
    June 2022
27. JIN J
    Vitamins and Minerals to Prevent Cardiovascular Disease and Cancer.
    JAMA. 2022;327:2364.
    PubMed    
    
    
    
28. O'CONNOR EA, Evans CV, Ivlev I, Rushkin MC, et al
    Vitamin and Mineral Supplements for the Primary Prevention of Cardiovascular Disease and Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2022;327:2334-2347.
    PubMed     Abstract available
    
    
    
29. MANGIONE CM, Barry MJ, Nicholson WK, Cabana M, et al
    Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2022;327:2326-2333.
    PubMed     Abstract available
    
    
    
30. RUSSELL DW, Casey JD, Gibbs KW, Ghamande S, et al
    Effect of Fluid Bolus Administration on Cardiovascular Collapse Among Critically Ill Patients Undergoing Tracheal Intubation: A Randomized Clinical Trial.
    JAMA. 2022 Jun 16. pii: 2793545. doi: 10.1001/jama.2022.9792.
    PubMed     Abstract available
    
    
    May 2022
31. UEMURA T
    Moderate Hypothermia vs Normothermia and 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial ECMO.
    JAMA. 2022;327:1928.
    PubMed    
    
    
    
32. PAPPALARDO F, Montisci A
    Moderate Hypothermia vs Normothermia and 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial ECMO.
    JAMA. 2022;327:1927-1928.
    PubMed    
    
    
    
33. LEVY B, Combes A, Girerd N
    Moderate Hypothermia vs Normothermia and 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial ECMO-Reply.
    JAMA. 2022;327:1928-1929.
    PubMed    
    
    
    April 2022
34. DAVIDSON KW, Barry MJ, Mangione CM, Cabana M, et al
    Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2022;327:1577-1584.
    PubMed     Abstract available
    
    
    
35. BRETT AS
    Should Patients Take Aspirin for Primary Cardiovascular Prevention?: Updated Recommendations From the US Preventive Services Task Force.
    JAMA. 2022;327:1552-1554.
    PubMed    
    
    
    
36. JIN J
    Use of Aspirin to Prevent Cardiovascular Disease.
    JAMA. 2022;327:1624.
    PubMed    
    
    
    
37. GUIRGUIS-BLAKE JM, Evans CV, Perdue LA, Bean SI, et al
    Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2022;327:1585-1597.
    PubMed     Abstract available
    
    
    
38. DEHMER SP, O'Keefe LR, Evans CV, Guirguis-Blake JM, et al
    Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Modeling Study for the US Preventive Services Task Force.
    JAMA. 2022;327:1598-1607.
    PubMed     Abstract available
    
    
    
39. ABBASI J
    Highlights From the American College of Cardiology's Scientific Sessions-New Heart Failure Management Guidelines, Alirocumab After a Myocardial Infarction, and Treating Mild Chronic Hypertension in Pregnancy.
    JAMA. 2022 Apr 20. pii: 2791572. doi: 10.1001/jama.2022.5487.
    PubMed    
    
    
    
40. RABER L, Ueki Y, Otsuka T, Losdat S, et al
    Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial.
    JAMA. 2022 Apr 3. pii: 2790913. doi: 10.1001/jama.2022.5218.
    PubMed     Abstract available
    
    
    March 2022
41. BRUXVOORT K, Slezak J, Qian L, Sy LS, et al
    Association Between 2-Dose vs 3-Dose Hepatitis B Vaccine and Acute Myocardial Infarction.
    JAMA. 2022 Mar 25. pii: 2790492. doi: 10.1001/jama.2022.2540.
    PubMed     Abstract available
    
    
    
42. LIN YH
    Mental Stress-Induced Myocardial Ischemia and Cardiovascular Events in Patients With Coronary Heart Disease.
    JAMA. 2022;327:1091.
    PubMed    
    
    
    
43. VACCARINO V, Bremner JD, Quyyumi AA
    Mental Stress-Induced Myocardial Ischemia and Cardiovascular Events in Patients With Coronary Heart Disease-Reply.
    JAMA. 2022;327:1091-1092.
    PubMed    
    
    
    
44. ABBASI J
    The COVID Heart-One Year After SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks.
    JAMA. 2022 Mar 2. pii: 2789793. doi: 10.1001/jama.2022.2411.
    PubMed    
    
    
    
45. DALZELL JR
    Review of Cardiogenic Shock After Acute Myocardial Infarction.
    JAMA. 2022;327:878.
    PubMed    
    
    
    
46. SAMSKY MD, Rao SV
    Review of Cardiogenic Shock After Acute Myocardial Infarction-Reply.
    JAMA. 2022;327:879.
    PubMed    
    
    
    February 2022
47. BHATT DL, Lopes RD, Harrington RA
    Diagnosis and Treatment of Acute Coronary Syndromes: A Review.
    JAMA. 2022;327:662-675.
    PubMed     Abstract available
    
    
    
48. LEVY B, Girerd N, Amour J, Besnier E, et al
    Effect of Moderate Hypothermia vs Normothermia on 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation: A Randomized Clinical Trial.
    JAMA. 2022;327:442-453.
    PubMed     Abstract available
    
    
    January 2022
49. ABBASI J
    Highlights From the American Heart Association's Scientific Sessions-ApoB as a Risk Marker, an Oral PCSK9 Inhibitor, and Aspirin and Dementia.
    JAMA. 2022;327:310-312.
    PubMed    
    
    
    December 2021
50. SLOMSKI A
    Tirzepatide Tested for Type 2 Diabetes With High Cardiovascular Risk.
    JAMA. 2021;326:2464.
    PubMed    
    
    
    
51. GREENE SJ, Butler J, Fonarow GC
    Contextualizing Risk Among Patients With Heart Failure.
    JAMA. 2021;326:2261-2262.
    PubMed    
    
    
    
52. RAY KK, Wright RS
    Clinical Update on Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk.
    JAMA. 2021;326:2205.
    PubMed    
    
    
    
53. WILKINS JT, Lloyd-Jones DM
    Clinical Update on Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk-Reply.
    JAMA. 2021;326:2205-2206.
    PubMed    
    
    
    November 2021
54. NACHTIGALL M, Nachtigall RH
    The Role of Lipoprotein(a) in Cardiovascular Diseases.
    JAMA. 2021;326:2078.
    PubMed    
    
    
    
55. NATARAJAN P, Miksenas H, Januzzi JL Jr
    The Role of Lipoprotein(a) in Cardiovascular Diseases-Reply.
    JAMA. 2021;326:2078-2079.
    PubMed    
    
    
    
56. SLOMSKI A
    Intensive Blood Pressure Control Lowers Cardiovascular Risk.
    JAMA. 2021;326:2001.
    PubMed    
    
    
    
57. JABAGI MJ, Botton J, Bertrand M, Weill A, et al
    Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older.
    JAMA. 2021 Nov 22. pii: 2786667. doi: 10.1001/jama.2021.21699.
    PubMed    
    
    
    
58. AMINIAN A, Al-Kurd A, Wilson R, Bena J, et al
    Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.
    JAMA. 2021 Nov 11. pii: 2786270. doi: 10.1001/jama.2021.19569.
    PubMed     Abstract available
    
    
    
59. VACCARINO V, Almuwaqqat Z, Kim JH, Hammadah M, et al
    Association of Mental Stress-Induced Myocardial Ischemia With Cardiovascular Events in Patients With Coronary Heart Disease.
    JAMA. 2021;326:1818-1828.
    PubMed     Abstract available
    
    
    
60. SAMSKY MD, Morrow DA, Proudfoot AG, Hochman JS, et al
    Cardiogenic Shock After Acute Myocardial Infarction: A Review.
    JAMA. 2021;326:1840-1850.
    PubMed     Abstract available
    
    
    
61. BRAVO PE, Cappola TP
    Mental Stress-Induced Myocardial Ischemia: When the Mind Controls the Fate of the Heart.
    JAMA. 2021;326:1803-1804.
    PubMed    
    
    
    October 2021
62. SAAD M, Kennedy KF, Imran H, Louis DW, et al
    Association Between COVID-19 Diagnosis and In-Hospital Mortality in Patients Hospitalized With ST-Segment Elevation Myocardial Infarction.
    JAMA. 2021 Oct 29. pii: 2785893. doi: 10.1001/jama.2021.18890.
    PubMed     Abstract available
    
    
    
63. FANAROFF AC, Garcia S, Giri J
    Myocardial Infarction During the COVID-19 Pandemic.
    JAMA. 2021 Oct 29. pii: 2785894. doi: 10.1001/jama.2021.19608.
    PubMed    
    
    
    
64. HE J, Zhu Z, Bundy JD, Dorans KS, et al
    Trends in Cardiovascular Risk Factors in US Adults by Race and Ethnicity and Socioeconomic Status, 1999-2018.
    JAMA. 2021;326:1286-1298.
    PubMed     Abstract available
    
    
    September 2021
65. ZUIN M, Rigatelli G, Zuliani G
    Association of Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention With Memory Decline in Older Adults.
    JAMA. 2021;326:1212-1213.
    PubMed    
    
    
    
66. WHITLOCK EL, Glymour MM
    Association of Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention With Memory Decline in Older Adults-Reply.
    JAMA. 2021;326:1213.
    PubMed    
    
    
    August 2021
67. 
    Worse Cardiovascular Outcomes Found in Disadvantaged Areas.
    JAMA. 2021;326:591.
    PubMed    
    
    
    July 2021
68. SLOMSKI A
    Fewer Cardiovascular Events With Intensive Blood Pressure Control.
    JAMA. 2021;326:299.
    PubMed    
    
    
    
69. WILKINS JT, Lloyd-Jones DM
    Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk.
    JAMA. 2021;326:266-267.
    PubMed    
    
    
    
70. MIKSENAS H, Januzzi JL Jr, Natarajan P
    Lipoprotein(a) and Cardiovascular Diseases.
    JAMA. 2021 Jul 8. pii: 2781946. doi: 10.1001/jama.2021.3632.
    PubMed    
    
    
    June 2021
71. SATO T, Terada R, Ikeda T
    Effect of Restrictive or Liberal Blood Transfusion on Major Cardiovascular Events in Patients With Acute Myocardial Infarction and Anemia.
    JAMA. 2021;325:2505-2506.
    PubMed    
    
    
    
72. DUCROCQ G, Simon T, Steg PG
    Effect of Restrictive or Liberal Blood Transfusion on Major Cardiovascular Events in Patients With Acute Myocardial Infarction and Anemia-Reply.
    JAMA. 2021;325:2506-2507.
    PubMed    
    
    
    
73. SOLOMON MD, Nguyen-Huynh M, Leong TK, Alexander J, et al
    Changes in Patterns of Hospital Visits for Acute Myocardial Infarction or Ischemic Stroke During COVID-19 Surges.
    JAMA. 2021 Jun 2. pii: 2780794. doi: 10.1001/jama.2021.8414.
    PubMed    
    
    
    May 2021
74. GOTTESMAN RF, Johansen MC
    Coronary Revascularization and Cognitive Decline: The Patient or the Procedure?
    JAMA. 2021;325:1941-1942.
    PubMed    
    
    
    
75. OGATA H, Fukagawa M, Hirakata H, Kagimura T, et al
    Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial.
    JAMA. 2021;325:1946-1954.
    PubMed     Abstract available
    
    
    
76. WHITLOCK EL, Diaz-Ramirez LG, Smith AK, Boscardin WJ, et al
    Association of Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention With Memory Decline in Older Adults Undergoing Coronary Revascularization.
    JAMA. 2021;325:1955-1964.
    PubMed     Abstract available
    
    
    
77. JOSHI PH, de Lemos JA
    Diagnosis and Management of Stable Angina: A Review.
    JAMA. 2021;325:1765-1778.
    PubMed     Abstract available
    
    
    April 2021
78. EL-BATTRAWY I, Behnes M, Akin I
    Depression and Incident Cardiovascular Disease.
    JAMA. 2021;325:1679-1680.
    PubMed    
    
    
    
79. DAVIDSON KW, Pennells L, Di Angelantonio E
    Depression and Incident Cardiovascular Disease-Reply.
    JAMA. 2021;325:1680.
    PubMed    
    
    
    
80. ANCHAN R, Cifu AS, Paul J
    Management of Acute Coronary Syndromes in Patients Without Persistent ST-Segment Elevation.
    JAMA. 2021;325:1556-1557.
    PubMed    
    
    
    
81. RIGATELLI G, Zuin M
    Fractional Flow Reserve Treatment and Major Adverse Cardiac Events in Patients With Coronary Artery Disease.
    JAMA. 2021;325:1565.
    PubMed    
    
    
    
82. SUD M, Fang J, Ko DT
    Fractional Flow Reserve Treatment and Major Adverse Cardiac Events in Patients With Coronary Artery Disease-Reply.
    JAMA. 2021;325:1565-1566.
    PubMed    
    
    
    
83. KAMRAN H, Jneid H, Kayani WT, Virani SS, et al
    Oral Antiplatelet Therapy After Acute Coronary Syndrome: A Review.
    JAMA. 2021;325:1545-1555.
    PubMed     Abstract available
    
    
    
84. WANG Y
    Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk.
    JAMA. 2021;325:1333.
    PubMed    
    
    
    
85. OLSHANSKY B, Bhatt DL, Chung MK
    Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk.
    JAMA. 2021;325:1332-1333.
    PubMed    
    
    
    
86. PARK KY, Park HK, Hwang HS
    Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk.
    JAMA. 2021;325:1334.
    PubMed    
    
    
    
87. WELTY F, Bistrian B, Driscoll D
    Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk.
    JAMA. 2021;325:1333.
    PubMed    
    
    
    
88. NISSEN SE, Lincoff AM, Nicholls SJ
    Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk-Reply.
    JAMA. 2021;325:1334-1335.
    PubMed    
    
    
    March 2021
89. SLOMSKI A
    Polypill Plus Aspirin Effective for Cardiovascular Disease Prevention.
    JAMA. 2021;325:1135.
    PubMed    
    
    
    
90. FRIEDEN TR, Foti KE
    National Initiatives to Prevent Myocardial Infarction and Stroke.
    JAMA. 2021 Mar 12. pii: 2777651. doi: 10.1001/jama.2021.0905.
    PubMed    
    
    
    
91. YOU SC, Gupta A, Krumholz HM
    Ticagrelor vs Clopidogrel for Patients With Acute Coronary Syndrome Undergoing Percutaneous Intervention-Reply.
    JAMA. 2021;325:890-891.
    PubMed    
    
    
    
92. KIM HK, Kubica J, Jeong YH
    Ticagrelor vs Clopidogrel for Patients With Acute Coronary Syndrome Undergoing Percutaneous Intervention.
    JAMA. 2021;325:890.
    PubMed    
    
    
    February 2021
93. KOLTE D, Libby P, Jang IK
    New Insights Into Plaque Erosion as a Mechanism of Acute Coronary Syndromes.
    JAMA. 2021 Feb 22. pii: 2776938. doi: 10.1001/jama.2021.0069.
    PubMed    
    
    
    
94. PERAK AM, Lancki N, Kuang A, Labarthe DR, et al
    Associations of Maternal Cardiovascular Health in Pregnancy With Offspring Cardiovascular Health in Early Adolescence.
    JAMA. 2021;325:658-668.
    PubMed     Abstract available
    
    
    
95. DANIELS SR
    Maternal Cardiovascular Health: A Critical Period for Offspring Lifetime Cardiovascular Health?
    JAMA. 2021;325:630-631.
    PubMed    
    
    
    
96. DUCROCQ G, Gonzalez-Juanatey JR, Puymirat E, Lemesle G, et al
    Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial.
    JAMA. 2021;325:552-560.
    PubMed     Abstract available
    
    
    
97. KHATANA SAM, Venkataramani AS, Nathan AS, Dayoub EJ, et al
    Association Between County-Level Change in Economic Prosperity and Change in Cardiovascular Mortality Among Middle-aged US Adults.
    JAMA. 2021;325:445-453.
    PubMed     Abstract available
    
    
    
98. WEEKS WB, Weinstein JN
    Economic Prosperity and Cardiovascular Mortality: Further Evidence That All Policy Is Health Policy.
    JAMA. 2021;325:439-440.
    PubMed    
    
    
    January 2021
99. LOPES RD, Macedo AVS, de Barros E Silva PGM, Moll-Bernardes RJ, et al
    Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial.
    JAMA. 2021;325:254-264.
    PubMed     Abstract available
    
    
    December 2020
100. SLOMSKI A
     Empagliflozin Cuts Cardiovascular Deaths in Advanced Heart Failure.
     JAMA. 2020;324:2476.
     PubMed    
     
     
     
101. HARSHFIELD EL, Pennells L, Schwartz JE, Willeit P, et al
     Association Between Depressive Symptoms and Incident Cardiovascular Diseases.
     JAMA. 2020;324:2396-2405.
     PubMed     Abstract available
     
     
     
102. PATEL MM, Uyeki TM
     Influenza Vaccine for Patients With High-risk Cardiovascular Disease.
     JAMA. 2020 Dec 4. pii: 2773988. doi: 10.1001/jama.2020.23948.
     PubMed    
     
     
     
103. VARDENY O, Kim K, Udell JA, Joseph J, et al
     Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial.
     JAMA. 2020 Dec 4. pii: 2773989. doi: 10.1001/jama.2020.23649.
     PubMed     Abstract available
     
     
     November 2020
104. KRIST AH, Davidson KW, Mangione CM, Barry MJ, et al
     Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: US Preventive Services Task Force Recommendation Statement.
     JAMA. 2020;324:2069-2075.
     PubMed     Abstract available
     
     
     
105. O'CONNOR EA, Evans CV, Rushkin MC, Redmond N, et al
     Behavioral Counseling to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
     JAMA. 2020;324:2076-2094.
     PubMed     Abstract available
     
     
     
106. JIN J
     Counseling on Healthy Diet and Physical Activity to Prevent Cardiovascular Disease.
     JAMA. 2020;324:2114.
     PubMed    
     
     
     
107. SMILOWITZ NR, Berger JS
     Cardiovascular Risk Assessment for Noncardiac Surgery-Reply.
     JAMA. 2020;324:2106-2107.
     PubMed    
     
     
     
108. GRASSHOFF C, Magunia H
     Cardiovascular Risk Assessment for Noncardiac Surgery.
     JAMA. 2020;324:2105-2106.
     PubMed    
     
     
     
109. KHAN SS, Greenland P
     Comprehensive Cardiovascular Health Promotion for Successful Prevention of Cardiovascular Disease.
     JAMA. 2020;324:2036-2037.
     PubMed    
     
     
     
110. SHARMA G, Martin SS, Blumenthal RS
     Effects of Omega-3 Fatty Acids on Major Adverse Cardiovascular Events: What Matters Most: the Drug, the Dose, or the Placebo?
     JAMA. 2020 Nov 15. pii: 2773118. doi: 10.1001/jama.2020.22387.
     PubMed    
     
     
     
111. NICHOLLS SJ, Lincoff AM, Garcia M, Bash D, et al
     Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
     JAMA. 2020 Nov 15. pii: 2773120. doi: 10.1001/jama.2020.22258.
     PubMed     Abstract available
     
     
     
112. SUD M, Han L, Koh M, Austin PC, et al
     Association Between Adherence to Fractional Flow Reserve Treatment Thresholds and Major Adverse Cardiac Events in Patients With Coronary Artery Disease.
     JAMA. 2020 Nov 13. pii: 2773127. doi: 10.1001/jama.2020.22708.
     PubMed     Abstract available
     
     
     
113. BACH RG
     Physiology-Based Revascularization Decisions and Improved Clinical Outcomes Following Percutaneous Coronary Interventions.
     JAMA. 2020 Nov 13. pii: 2773126. doi: 10.1001/jama.2020.22998.
     PubMed    
     
     
     October 2020
114. SLOMSKI A
     Colchicine Reduces Cardiovascular Events in Chronic Coronary Disease.
     JAMA. 2020;324:1599.
     PubMed    
     
     
     
115. BATES ER
     Net Adverse Clinical Events With Antiplatelet Therapy in Acute Coronary Syndromes.
     JAMA. 2020;324:1613-1615.
     PubMed    
     
     
     
116. YOU SC, Rho Y, Bikdeli B, Kim J, et al
     Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
     JAMA. 2020;324:1640-1650.
     PubMed     Abstract available
     
     
     June 2020
117. HADAYA J, Benharash P
     Extracorporeal Membrane Oxygenation.
     JAMA. 2020;323:2536.
     PubMed    
     
     
     May 2020
118. HIRSCH IB, Gaudiani LM
     Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020.
     JAMA. 2020 May 22. pii: 2766597. doi: 10.1001/jama.2020.1303.
     PubMed    
     
     
     February 2020
119. THIELE H, Desch S, Freund A
     Microaxial Left Ventricular Assist Devices: In Search of an Appropriate Indication.
     JAMA. 2020;323:716-718.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: